Syncona Shs GBP (GB:SYNC)
LSE:SYNC
Want to see GB:SYNC full AI Analyst Report?
SYNC Stock Chart & Stats
93.90 p
1.15 p(1.28%)
At close: 4:00 PM EST
93.90 p
1.15 p(1.28%)
Day’s Range― - ―
52-Week Range79.60 p - 102.60 p
Previous CloseN/A
Volume94.05K
Average Volume (3M)483.92K
Market Cap
N/A
Enterprise Value595.82M
Total Cash (Recent Filing)£213.00K
Total Debt (Recent Filing)£0.00
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Jun 11, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.15
Shares Outstanding608,193,050
10 Day Avg. Volume510,558
30 Day Avg. Volume483,919
Financial Highlights & Ratios
PEG Ratio<0.01
Price to Book (P/B)0.51
Price to Sales (P/S)-7.82
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)<0.01
Revenue Forecast (FY)£49.14M
Bulls Say, Bears Say
Bulls Say
Balance Sheet StrengthZero reported debt materially lowers financial distress risk and gives management durable optionality to fund follow-on investments, support portfolio companies through clinical cycles, or execute buybacks/returns without refinancing. This cushion improves resilience over multiple biotech cycles and supports strategic capital allocation over the next 2–6 months and beyond.
Active Capital-allocation ActionsA committed program to crystallise value from mature holdings and launch a private fund signals structural progress in portfolio monetization and funding diversification. These actions help convert unrealized gains to distributable capital, reduce concentration risk, and create repeatable pathways for liquidity and reinvestment, improving shareholder returns and strategic flexibility over the medium term.
Focused Life-sciences Investment ModelA specialist model centered on creating and scaling biotech companies leverages domain expertise and deep sector relationships, increasing the chance of outperforming generalist investors in translating scientific milestones into value. This concentrated, founder-led approach supports durable alpha generation through multi-stage value creation from inception to exit.
Bears Say
Earnings VolatilitySharp swings in reported earnings reduce predictability of returns and make operational planning and investor forecasting difficult. For an investment vehicle, volatile P&L driven by market revaluations or one-off events undermines assessment of recurring performance and raises execution risk for multi-quarter capital deployment and shareholder-return targets.
Inconsistent Cash GenerationIrregular operating and free cash flow constrains the company's ability to reliably fund follow-on investments, cover operating costs, or sustain buybacks without asset sales or new capital. This variability increases the likelihood of opportunistic disposals or dilution in down cycles and complicates multi-period capital allocation plans.
Dependence On Investment RevaluationsA business model that relies on unrealized fair-value changes and discrete exits creates structural earnings volatility and timing risk. Valuation-driven profits are subject to external market sentiment, clinical readouts, and acquisition timing, reducing steady cash income and making forward guidance, dividend predictability, and short-term liquidity planning less reliable.
Syncona Shs GBP News
SYNC FAQ
What was Syncona Shs GBP ’s price range in the past 12 months?
Syncona Shs GBP lowest share price was 79.60 p and its highest was 102.60 p in the past 12 months.
What is Syncona Shs GBP ’s market cap?
Currently, no data Available
When is Syncona Shs GBP ’s upcoming earnings report date?
Syncona Shs GBP ’s upcoming earnings report date is Jun 11, 2026 which is in 17 days.
How were Syncona Shs GBP ’s earnings last quarter?
Syncona Shs GBP released its earnings results on Nov 13, 2025. The company reported -0.042 p earnings per share for the quarter, missing the consensus estimate of N/A by -0.042 p.
Is Syncona Shs GBP overvalued?
According to Wall Street analysts Syncona Shs GBP ’s price is currently Overvalued.
Does Syncona Shs GBP pay dividends?
Syncona Shs GBP pays a Annually dividend of 2.3 p which represents an annual dividend yield of N/A. See more information on Syncona Shs GBP dividends here
What is Syncona Shs GBP ’s EPS estimate?
Syncona Shs GBP ’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Syncona Shs GBP have?
Syncona Shs GBP has 608,193,050 shares outstanding.
What happened to Syncona Shs GBP ’s price movement after its last earnings report?
Syncona Shs GBP reported an EPS of -0.042 p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.599%.
Which hedge fund is a major shareholder of Syncona Shs GBP ?
Currently, no hedge funds are holding shares in GB:SYNC
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Syncona Shs GBP
Syncona Limited is a fund specializes in investments in hedge, equity and long-term alternative investment funds across multiple asset classes. It manages private equity, debt, fixed income and alternative investments. The fund prefers to invest in healthcare and life sciences sector with focus on Cell therapy, gene therapy, biologics and small molecules. The fund invests in the public equity and fixed income markets across the globe. It targets attractive medium to long term returns by investing in leading long-only and alternative investment funds with proven managers and across multiple asset classes. The firm invests in separately managed account portfolios.
Technical Analysis
Ashmore Group PLC
―
Molten Ventures
―
IP Group plc
―
Mercia Asset Management
―
Caledonia Investments
―
Options Prices
Currently, No data available
---